Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis
Abstract:
Myeloid-derived suppressor cells (MDSCs) comprise immature myeloid populations produced in diverse pathologies, including neoplasia. Because MDSCs can impair antitumor immunity, these cells have emerged as a significant barrier to cancer therapy. Although much research has focused on how MDSCs promote tumor progression, it remains unclear how MDSCs develop and why the MDSC response is heavily granulocytic. Given that MDSCs are a manifestation of aberrant myelopoiesis, we hypothesized that MDSCs arise from perturbations in the regulation of interferon regulatory factor-8 (IRF-8), an integral transcriptional component of myeloid differentiation and lineage commitment. Overall, we demonstrated that (a) Irf8-deficient mice generated myeloid populations highly homologous to tumor-induced MDSCs with respect to phenotype, function, and gene expression profiles; (b) IRF-8 overexpression in mice attenuated MDSC accumulation and enhanced immunotherapeutic efficacy; (c) the MDSC-inducing factors G-CSF and GM-CSF facilitated IRF-8 downregulation via STAT3- and STAT5-dependent pathways; and (d) IRF-8 levels in MDSCs of breast cancer patients declined with increasing MDSC frequency, implicating IRF-8 as a negative regulator in human MDSC biology. Together, our results reveal a previously unrecognized role for IRF-8 expression in MDSC subset development, which may provide new avenues to target MDSCs in neoplasia.
Insights
Interferon regulatory factor-8 (IRF-8) deficiency drives the development of myeloid-derived suppressor cells (MDSCs). Restoring IRF-8 levels may offer new strategies to target MDSCs in cancer therapy.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells that impair anti-tumor immunity and pose a barrier to cancer therapy.
- The precise mechanisms governing MDSC development and their granulocytic bias remain incompletely understood.
- Aberrant myelopoiesis, potentially linked to transcriptional regulators, is implicated in MDSC generation.
Purpose of the Study:
- To investigate the role of interferon regulatory factor-8 (IRF-8) in the development and regulation of MDSCs.
- To determine if IRF-8 perturbations contribute to the aberrant myelopoiesis observed in MDSC populations.
- To explore the therapeutic potential of modulating IRF-8 levels for cancer treatment.
Main Methods:
- Utilized Irf8-deficient mice to model MDSC development.
- Overexpressed IRF-8 in mice to assess its impact on MDSC accumulation and immunotherapy.
- Investigated the influence of G-CSF and GM-CSF on IRF-8 expression via STAT3 and STAT5 pathways.
- Analyzed IRF-8 levels in MDSCs from breast cancer patients.
Main Results:
- Irf8-deficient mice exhibited myeloid populations phenotypically and functionally similar to tumor-induced MDSCs.
- IRF-8 overexpression reduced MDSC accumulation and improved the efficacy of cancer immunotherapy.
- Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) downregulated IRF-8 through STAT3/STAT5.
- Decreased IRF-8 levels correlated with increased MDSC frequency in breast cancer patients.
Conclusions:
- IRF-8 acts as a critical negative regulator in the development of myeloid-derived suppressor cells.
- Dysregulation of IRF-8 contributes to the expansion of MDSCs in neoplastic conditions.
- Targeting IRF-8 presents a novel therapeutic strategy for overcoming MDSC-mediated immunosuppression in cancer.
More Related Videos
Related Concept Videos
Master Transcription Regulators
Lineage Commitment
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...


